Q2 2026 saw 3% sales growth and a 9% EBIT increase, with strong cash flow and margin expansion. Five acquisitions and one divestment were completed, while organic growth was robust in EMEIA and Americas but declined in Asia Pacific. Guidance anticipates continued acquisition-driven growth but margi…
Q2 2026 saw 3% sales growth and a 9% EBIT increase, with strong cash flow and margin expansion. Five acquisitions and one divestment were completed, while organic growth was robust in EMEIA and Americas but declined in Asia Pacific. Guidance anticipates continued acquisition-driven growth but margin dilution.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.